Professor Paula Colavita, PhD, is Chief Technology Officer at Glycome BioPharma. She has unique experience in the design and development of advanced functional materials. She is the author of over 80 publications in international journals and co-inventor of two patents and leads a research team at Trinity College Dublin (Ireland), whose activities focus on understanding and achieving control of interfacial processes and reactions. Prof Colavita completed her PhD at the University of South Carolina (US) and carried out postdoctoral research work at the University of Wisconsin-Madison (US).
Shane Smith, Eoin Scanlan and Paula Colavita discusses the difficulty inherent in developing parenteral biologic products due to the challenge of creating a stable formulation in the face of surface-mediated protein aggregation and introduces Pro-Tects – Glycome’s patented surface-treatment technology platform that offers a solution to this critical issue without introducing further development challenges.